Imperva (IMPV) PT Raised to $64 at RBC Capital
Tweet
Share
E-mail
Get Alerts IMPV Hot Sheet
Price: $55.74 --0%
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
RBC Capital raised its price target on Imperva (NASDAQ: IMPV) to $64.00 (from $54.00) while maintaining an Outperform rating.
Analyst Matthew Hedberg is looking for in-line to slightly above consensus results.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RCM Technologies (RCMT) PT Raised to $45 at Benchmark on Q2 Beat
- Broadridge Financial (BR) PT Raised to $180 at UBS, Neutral Rating Maintained
- Target (TGT) PT Raised to $170 at DA Davidson Ahead of Q2 Earnings
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
